Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Heather Boerner is an award-winning journalist who specializes in storytelling on healthcare issues. She's most interested in how people choose between equally important needs.
HIV diagnoses dropped significantly in the COVID era, but the CDC is not drawing conclusions from that.
Data from 42,000 people with HIV suggest that income and Medicaid coverage play a role in unintentional weight loss.
PrEP prescriptions are supposed to be free to users now, which could go a long way toward leveling the HIV-prevention playing field.
People with HIV, medical societies and women’s health organizations sound off on the SCOTUS draft that proposes to overrule Roe v. Wade.
Telemedicine is an increasingly used to provide convenient PrEP services. But are these programs following U.S. guidelines?
Just 1 in 10 eligible menopausal women have used hormone therapy to treat hot flashes and other symptoms.
The White House strategy embraces syringe services, access to housing and naloxone as three science-based approaches.
Currently, fewer than 1 in 10 women eligible for HIV prevention medications are taking them.
The approval makes this the first single-pill regimen containing dolutegravir available in a water-dispersible formulation.
An eight-year review of medical records shows that PrEP persistence is associated with higher income and private insurance.
Pickings for concurrent treatment are slim in Ending the HIV Epidemic rural communities.
Previous research has shown low rates of use of HIV prevention products, but the tide could be turning.
However, the benefit would be less evident in Georgia, the state with the highest lifetime risk of acquiring HIV.
Nine out of the 10 areas with the highest likelihood of being diagnosed with HIV are located in the South.
It’s not race itself but the lingering effects of racism and community disinvestment that lead to higher HIV rates among Black people.
New HIV treatment guidelines boost TAF and dolutegravir but warn about Trogarzo and advise against Cabenuva for pregnant people.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.